Skip to main content
. 2022 Nov 24;22:407. doi: 10.1186/s12893-022-01848-w

Fig. 4.

Fig. 4

The OS rates of HBV- associated HCC patients using PSM (1:1) comparative analyses of ALPPS with TACE. A There was no statistical difference in OS rates of HBV-associated HCC patients between ALPPS and TACE (n = 21, p = 0.383); B There was a significant difference in OS rates of HBV-associated HCC patients (BCLC stage B and C between ALPPS and TACE (n = 16, p = 0.041)